Home
About
Contact
DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Your search for
Oncology (Adult) | All Regions
returned
230
studies.
Active, currently enrolling
Who can join
EXActDNA-003 / NSABP B-64: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease
Keywords:
Oncology (Adult);Breast Cancer; ctDNA; Neoplasms by Site; Neoplasms; Breast…
Study Type:
OBSERVATIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (DatoDXd) With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)
Keywords:
Breast Cancer; TNBC; Triple-negative; Adjuvant; Datopotamab Deruxtecan;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Keywords:
Oncology (Adult); Pro00014171; Multiple Myeloma; Lymphoma,…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
Keywords:
Oncology (Adult);Gastroenterology;
Study Type:
OBSERVATIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Keywords:
Prostatic Neoplasms; Genital Neoplasms; Male; Urogenital Neoplasms; Neoplasms by…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
CASPAR - A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer
Keywords:
Oncology (Adult);Urology; Genital Neoplasms, Male; Urogenital…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, not yet recruiting
Who can join
A Phase 3 Randomized, Double-Blind, Active-Controlled Study of Palazestrant with Ribociclib Versus Letrozole with Ribociclib for the First-Line Treatment of ER+, HER2 Advanced Breast Cancer (OPERA-02)
Keywords:
Oncology (Adult);
Study Type:
INTERVENTIONAL |
Region:
Hawaii
Enrollment complete
Who can join
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Keywords:
Oncology (Adult); Neoplasms, Glandular and Epithelial; Neoplasms by Histologic…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Randomized Phase II/III Study of Docetaxel and Ramucirumab With or Without Cemiplimab for Participants Previously Treated With Platinum-Based Chemotherapy and Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
Keywords:
Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Bronchogenic,…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)
Keywords:
Lung Neoplasms; Carcinoma; Non-Small-Cell Lung; Respiratory Tract Neoplasms;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
1
2
3
4
5
6
7
8
9
10
...